Insider filing · ATAI

Christian Angermayer bought $22.8M of AtaiBeckley (ATAI)

Executed Feb 14 2025, disclosed Feb 19 2025, 5 days later.

Over the 21 trading sessions from the disclosed entry session (Feb 19 2025), the stock returned -32.2% (delay-adjusted); from the execution session (Feb 14 2025), -36.2%. Derived: entry at the session's open, exit at the close 20 sessions later.

CA Christian Angermayer Director profile →

Christian Angermayer (Director) filed 3 Form 4 reports in the past 24 months (3 purchases, 0 sales), most often in AtaiBeckley Inc. (ATAI). Across 3 priced purchase filings, the average 21-session return was -6.9% from execution and -3.8% from disclosure (delay-adjusted; derived). The largest single filing was $22.8M of ATAI (10,835,718 sh × $2.10, as filed), executed Feb 14 2025.

ATAI AtaiBeckley Inc. ATAI · Healthcare · 10 filings in 24 months ticker →

Healthcare · AtaiBeckley Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→